Symptom changes in five dimensions of the Positive and Negative Syndrome Scale in refractory psychosis

被引:0
作者
Todd S. Woodward
Kwanghee Jung
Geoffrey N. Smith
Heungsun Hwang
Alasdair M. Barr
Ric M. Procyshyn
Sean W. Flynn
Mark van der Gaag
William G. Honer
机构
[1] University of British Columbia,Department of Psychiatry
[2] BC Mental Health and Addictions Research Institute,Department of Pediatrics
[3] University of Texas Health Science Center,Department of Psychology
[4] McGill University,Department of Anesthesiology, Pharmacology and Therapeutics
[5] University of British Columbia,Department of Clinical Psychology and EMGO Institute for Health and Care Research
[6] VU University,undefined
[7] Parnassia Psychiatric Institute,undefined
来源
European Archives of Psychiatry and Clinical Neuroscience | 2014年 / 264卷
关键词
Refractory psychosis; Positive and Negative Syndrome Scale (PANSS); Structural equation modeling; Schizophrenia; Schizoaffective disorder; Depression;
D O I
暂无
中图分类号
学科分类号
摘要
Refractory psychosis units currently have little information regarding which symptoms profiles should be expected to respond to treatment. In the current study, we provide this information using structural equation modeling of Positive and Negative Syndrome Scale (PANSS) ratings at admission and discharge on a sample of 610 patients admitted to a treatment refractory psychosis program at a Canadian tertiary care unit between 1990 and 2011. The hypothesized five-dimensional structure of the PANSS fit the data well at both admission and discharge, and the latent variable scores are reported as a function of symptom dimension and diagnostic category. The results suggest that, overall, positive symptoms (POS) responded to treatment better than all other symptoms dimensions, but for the schizoaffective and bipolar groups, greater response on POS was observed relative to the schizophrenia and major depression groups. The major depression group showed the most improvement on negative symptoms and emotional distress, and the bipolar group showed the most improvement on disorganization. Schizophrenia was distinct from schizoaffective disorder in showing reduced treatment response on all symptom dimensions. These results can assist refractory psychosis units by providing information on how PANSS symptom dimensions respond to treatment and how this depends on diagnostic category.
引用
收藏
页码:673 / 682
页数:9
相关论文
共 50 条
  • [31] Disorganization/Cognitive and Negative Symptom Dimensions in the At-Risk Mental State Predict Subsequent Transition to Psychosis
    Demjaha, Arsime
    Valmaggia, Lucia
    Stahl, Daniel
    Byrne, Majella
    McGuire, Philip
    SCHIZOPHRENIA BULLETIN, 2012, 38 (02) : 351 - 359
  • [32] Structural Differences within Negative and Depressive Syndrome Dimensions in Schizophrenia, Organic Brain Disease, and Major Depression: A Confirmatory Factor Analysis of the Positive and Negative Syndrome Scale
    Eisenberg, Daniel P.
    Aniskin, Dmitry B.
    White, Leonard
    Stein, Judith A.
    Harvey, Philip D.
    Galynker, Igor I.
    PSYCHOPATHOLOGY, 2009, 42 (04) : 242 - 248
  • [33] The interrater reliability of the Positive and Negative Syndrome Scale (PANSS)
    Bentsen, H
    Munkvold, OG
    Notland, TH
    Boye, B
    Bjorge, H
    Lersbryggen, AB
    Oskarsson, KH
    BergLarsen, R
    Malt, UF
    INTERNATIONAL JOURNAL OF METHODS IN PSYCHIATRIC RESEARCH, 1996, 6 (04) : 227 - 235
  • [34] Negative symptom dimensions in first episode psychosis: Is there a difference between schizophrenia and non-schizophrenia spectrum disorders?
    Pelizza, Lorenzo
    Azzali, Silvia
    Paterlini, Federica
    Garlassi, Sara
    Scazza, Ilaria
    Chiri, Luigi Rocco
    Poletti, Michele
    Pupo, Simona
    Raballo, Andrea
    EARLY INTERVENTION IN PSYCHIATRY, 2021, 15 (06) : 1513 - 1521
  • [35] Predominance of Symptoms Over Time in Early-Onset Psychosis: A Principal Component Factor Analysis of the Positive and Negative Syndrome Scale
    Rapado-Castro, Marta
    Soutullo, Cesar
    Fraguas, David
    Arango, Celso
    Paya, Beatriz
    Castro-Fornieles, Josefina
    Gonzalez-Pinto, Ana
    Parellada, Mara
    Graell, Montserrat
    Baeza, Inmaculada
    Bombin, Igor
    JOURNAL OF CLINICAL PSYCHIATRY, 2010, 71 (03) : 327 - 337
  • [36] A forced five-dimensional factor analysis and concurrent validity of the Positive and Negative Syndrome Scale in Mexican schizophrenic patients
    Fresán, A
    De la Fuente-Sandoval, C
    Loyzaga, C
    García-Anaya, M
    Meyenberg, N
    Nicolini, H
    Apiquian, R
    SCHIZOPHRENIA RESEARCH, 2005, 72 (2-3) : 123 - 129
  • [37] On the use of the Positive and Negative Syndrome Scale in randomized clinical trials
    Nicotra, Eraldo
    Casu, Gianluca
    Piras, Sara
    Marchese, Giorgio
    SCHIZOPHRENIA RESEARCH, 2015, 165 (2-3) : 181 - 187
  • [38] Mapping of the health of the Nation Outcomes Scale (HoNOS) and Positive and Negative Symptom Scale (PANSS) to the EQ-5D-3L in psychosis patients using the PHAMOUS study
    Kleijburg, Anne
    Wijnen, Ben
    den Hollander, Wouter
    Evers, Silvia
    Kroon, Hans
    Lokkerbol, Joran
    EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2025, 25 (03) : 373 - 384
  • [39] Trajectories and Changes in Individual Items of Positive and Negative Syndrome Scale among Schizophrenia Patients Prior to Impending Relapse
    Wang, Dai
    Gopal, Srihari
    Li, Qingqin
    Baker, Susan
    Narayan, Vaibhav
    BIOLOGICAL PSYCHIATRY, 2017, 81 (10) : S263 - S263
  • [40] Trajectories and Changes in Individual Items of Positive and Negative Syndrome Scale Among Schizophrenia Patients Prior to Impending Relapse
    Manji, Husseini
    Wang, Dai
    Gopal, Srihari
    Li, Qingqin
    Wittenberg, Gayle
    Baker, Susan
    Narayan, Vaibhav
    NEUROPSYCHOPHARMACOLOGY, 2016, 41 : S407 - S407